In the study by Mattila et al. on biomarkers of coagulation in pancreatic tumors, the preoperative acute phase reactants fibrinogen and FVIII distinguished cancer from benign tumors [17, 18, 20]. This evidence concerns the gene F8 and benign neoplasm.